Promoter inhibition by DNA methylation: a reversible signal

Doerfler W, Weisshaar B, Hoeveler A, Knebel D, Muller U, Dobrzanski P, Lichtenberg U, Achten S, Hermann R (1988)
Gene 74(1): 129-133.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
Gene
Band
74
Zeitschriftennummer
1
Seite
129-133
ISSN
PUB-ID

Zitieren

Doerfler W, Weisshaar B, Hoeveler A, et al. Promoter inhibition by DNA methylation: a reversible signal. Gene. 1988;74(1):129-133.
Doerfler, W., Weisshaar, B., Hoeveler, A., Knebel, D., Muller, U., Dobrzanski, P., Lichtenberg, U., et al. (1988). Promoter inhibition by DNA methylation: a reversible signal. Gene, 74(1), 129-133. doi:10.1016/0378-1119(88)90268-5
Doerfler, W., Weisshaar, B., Hoeveler, A., Knebel, D., Muller, U., Dobrzanski, P., Lichtenberg, U., Achten, S., and Hermann, R. (1988). Promoter inhibition by DNA methylation: a reversible signal. Gene 74, 129-133.
Doerfler, W., et al., 1988. Promoter inhibition by DNA methylation: a reversible signal. Gene, 74(1), p 129-133.
W. Doerfler, et al., “Promoter inhibition by DNA methylation: a reversible signal”, Gene, vol. 74, 1988, pp. 129-133.
Doerfler, W., Weisshaar, B., Hoeveler, A., Knebel, D., Muller, U., Dobrzanski, P., Lichtenberg, U., Achten, S., Hermann, R.: Promoter inhibition by DNA methylation: a reversible signal. Gene. 74, 129-133 (1988).
Doerfler, W, Weisshaar, Bernd, Hoeveler, A, Knebel, D, Muller, U, Dobrzanski, P, Lichtenberg, U, Achten, S, and Hermann, R. “Promoter inhibition by DNA methylation: a reversible signal”. Gene 74.1 (1988): 129-133.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
Hoffmann AC, Vallböhmer D, Prenzel K, Metzger R, Heitmann M, Neiss S, Ling F, Hölscher AH, Schneider PM, Brabender J., J Cancer Res Clin Oncol 135(9), 2009
PMID: 19259700
Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
Schenk T, Stengel S, Goellner S, Steinbach D, Saluz HP., Genes Chromosomes Cancer 46(9), 2007
PMID: 17534929
On the biological significance of DNA methylation.
Doerfler W., Biochemistry (Mosc) 70(5), 2005
PMID: 15948705
Improving the safety of embryo technologies: possible role of genomic imprinting.
Young LE, Fairburn HR., Theriogenology 53(2), 2000
PMID: 10735055
Lipotrope-modified diets enhance nitrosomethylurea-induced mammary carcinogenesis in female rats.
Choi CB, Baik MG, Keller WL, Park CS., Nutr Cancer 20(3), 1993
PMID: 7509056
Initial characterization of the four promoters of the human insulin-like growth factor II gene.
van Dijk MA, van Schaik FM, Bootsma HJ, Holthuizen P, Sussenbach JS., Mol Cell Endocrinol 81(1-3), 1991
PMID: 1797589
Hypomethylation of the interphotoreceptor retinoid-binding protein (IRBP) promotor and first exon is linked to expression of the gene.
Albini A, Toffenetti J, Zhu Z, Chader GJ, Noonan DM., Nucleic Acids Res 18(17), 1990
PMID: 2402443

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 2854801
PubMed | Europe PMC

Suchen in

Google Scholar